T. Rowe Price Associates
ICUI icon

T. Rowe Price Associates’s ICU Medical ICUI Stock Holding History

T. Rowe Price Associates’s Portfolio ICUI Stock Details ICUI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.66M Buy
28,314
+4,323
+18% +$621K ﹤0.01% 1562
2025
Q4 		$3.42M Buy
23,991
+1,008
+4% +$135K ﹤0.01% 1520
2025
Q3 		$2.76M Buy
22,983
+1,225
+6% +$155K ﹤0.01% 1602
2025
Q2 		$2.88M Buy
21,758
+2,933
+16% +$398K ﹤0.01% 1484
2025
Q1 		$2.62M Buy
18,825
+1,053
+6% +$163K ﹤0.01% 1495
2024
Q4 		$2.76M Buy
17,772
+2,578
+17% +$436K ﹤0.01% 1494
2024
Q3 		$2.77M Buy
15,194
+1,170
+8% +$173K ﹤0.01% 1489
2024
Q2 		$1.67M Buy
14,024
+2,309
+20% +$243K ﹤0.01% 1648
2024
Q1 		$1.26M Sell
11,715
-7,869
-40% -$782K ﹤0.01% 1802
2023
Q4 		$1.95M Sell
19,584
-28,836
-60% -$2.82M ﹤0.01% 1545
2023
Q3 		$5.76M Sell
48,420
-104,096
-68% -$15.5M ﹤0.01% 1152
2023
Q2 		$27.2M Sell
152,516
-14,596
-9% -$2.68M ﹤0.01% 855
2023
Q1 		$27.6M Sell
167,112
-58,146
-26% -$10M ﹤0.01% 837
2022
Q4 		$35.5M Sell
225,258
-45,939
-17% -$6.99M 0.01% 761
2022
Q3 		$40.8M Sell
271,197
-2,437,918
-90% -$406M 0.01% 713
2022
Q2 		$445M Buy
2,709,115
+1,274
+0% +$245K 0.06% 313
2022
Q1 		$603M Sell
2,707,841
-17,699
-0.6% -$3.96M 0.06% 297
2021
Q4 		$647M Buy
2,725,540
+30,030
+1% +$7.01M 0.06% 303
2021
Q3 		$629M Buy
2,695,510
+318,890
+13% +$66.9M 0.06% 307
2021
Q2 		$489M Sell
2,376,620
-201,200
-8% -$41.4M 0.05% 340
2021
Q1 		$530M Sell
2,577,820
-62,544
-2% -$13.2M 0.05% 323
2020
Q4 		$566M Sell
2,640,364
-15,633
-0.6% -$3.03M 0.06% 304
2020
Q3 		$485M Sell
2,655,997
-11,103
-0.4% -$2.09M 0.06% 305
2020
Q2 		$492M Sell
2,667,100
-7,131
-0.3% -$1.42M 0.06% 298
2020
Q1 		$540M Buy
2,674,231
+89,469
+3% +$17.2M 0.09% 245
2019
Q4 		$484M Sell
2,584,762
-33,648
-1% -$5.79M 0.06% 311
2019
Q3 		$418M Sell
2,618,410
-860,473
-25% -$171M 0.06% 311
2019
Q2 		$876M Buy
3,478,883
+640,425
+23% +$148M 0.12% 181
2019
Q1 		$679M Buy
2,838,458
+58,239
+2% +$14M 0.1% 211
2018
Q4 		$638M Buy
2,780,219
+2,508,062
+922% +$618M 0.11% 196
2018
Q3 		$77M Buy
272,157
+19,013
+8% +$5.57M 0.01% 756
2018
Q2 		$74.3M Buy
253,144
+13,306
+6% +$3.64M 0.01% 750
2018
Q1 		$60.5M Buy
239,838
+7,670
+3% +$1.8M 0.01% 809
2017
Q4 		$50.1M Sell
232,168
-4,737
-2% -$959K 0.01% 860
2017
Q3 		$44M Sell
236,905
-6,344
-3% -$1.11M 0.01% 897
2017
Q2 		$42M Buy
243,249
+908
+0.4% +$146K 0.01% 897
2017
Q1 		$37M Buy
242,341
+14,941
+7% +$2.18M 0.01% 917
2016
Q4 		$33.5M Buy
227,400
+8,750
+4% +$1.27M 0.01% 947
2016
Q3 		$27.6M Buy
218,650
+24,200
+12% +$2.92M 0.01% 1015
2016
Q2 		$21.9M Buy
194,450
+12,900
+7% +$1.34M ﹤0.01% 1070
2016
Q1 		$18.9M Buy
181,550
+42,410
+30% +$4.05M ﹤0.01% 1102
2015
Q4 		$15.7M Buy
139,140
+14,840
+12% +$1.64M ﹤0.01% 1156
2015
Q3 		$13.6M Buy
124,300
+4,200
+3% +$449K ﹤0.01% 1225
2015
Q2 		$11.5M Buy
120,100
+20,000
+20% +$1.87M ﹤0.01% 1314
2015
Q1 		$9.32M Buy
100,100
+5,400
+6% +$472K ﹤0.01% 1354
2014
Q4 		$7.76M Buy
94,700
+5,500
+6% +$422K ﹤0.01% 1387
2014
Q3 		$5.72M Buy
89,200
+500
+0.6% +$30.6K ﹤0.01% 1434
2014
Q2 		$5.39M Buy
88,700
+7,700
+10% +$455K ﹤0.01% 1447
2014
Q1 		$4.85M Buy
81,000
+900
+1% +$55.4K ﹤0.01% 1437
2013
Q4 		$5.1M Buy
80,100
+4,900
+7% +$315K ﹤0.01% 1429
2013
Q3 		$5.11M Buy
75,200
+2,700
+4% +$193K ﹤0.01% 1421
2013
Q2 		$5.22M Buy
+72,500
New +$4.79M ﹤0.01% 1400

Other funds holding ICUI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates's ICUI Position: Q1 2026 in Review

T. Rowe Price Associates increased its ICU Medical (ICUI) stake by 18% in Q1 2026, buying an estimated $621K and bringing the position to 28,314 shares worth $3.66M. The position accounts for ﹤0.01% of the portfolio, ranked #1562.

T. Rowe Price Associates first reported a position in ICUI in Q2 2013 and has held it in 52 quarters since. The position peaked at $876M in Q2 2019. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.

  • T. Rowe Price Associates held 28,314 shares of ICU Medical worth $3.66M as of Q1 2026.
  • T. Rowe Price Associates bought 4,323 ICU Medical shares in Q1 2026, an estimated $621K.
  • ICU Medical made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1562 holding.
  • T. Rowe Price Associates first reported a position in ICU Medical in Q2 2013 and has held it in 52 quarters since.
  • T. Rowe Price Associates's ICU Medical position peaked at $876M in Q2 2019.
  • 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.